Using Impedance Monitoring and Electrocorticography to Identify Brain Tumor Margins
Author Information
Author(s): Georgiannakis Ariadni, Chapman Christopher A. R., Paraskevopoulos Dimitrios
Primary Institution: Queen Mary University of London
Hypothesis
Measurements obtained by either impedance monitoring or electrocorticography can distinguish between tumor and healthy brain tissue intraoperatively.
Conclusion
Impedance and electrocorticography measurements can differentiate between tumor and unaffected tissue during surgery, but larger studies are needed to validate these findings.
Supporting Evidence
- Ten impedance studies showed significant differences in values between tumor and healthy tissue.
- Eight electrocorticography studies indicated increased high gamma power in tumor tissue.
- No studies integrated both impedance monitoring and electrocorticography in one device.
Takeaway
Doctors can use special tools to tell the difference between sick and healthy brain parts during surgery, which might help them remove all the bad parts.
Methodology
A systematic review was conducted following PRISMA guidelines, analyzing studies on electrocorticography and impedance monitoring in patients with brain tumors.
Potential Biases
High risk of bias was noted in 11 studies, with variability in study design impacting generalizability.
Limitations
The review included only English publications and was limited to studies with adult patients, potentially excluding relevant research.
Participant Demographics
Ages ranged from 18 to 88 years, with a male to female ratio of approximately 57.8% males.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website